Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones

Purpose To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery. Setting Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan. Methods Eyes of patie...

Full description

Saved in:
Bibliographic Details
Published inJournal of cataract and refractive surgery Vol. 35; no. 3; pp. 475 - 479
Main Authors Hori, Yuichi, MD, Nakazawa, Toru, MD, Maeda, Naoyuki, MD, Sakamoto, Masako, MS, Yokokura, Syunji, MD, Kubota, Akira, MD, Inoue, Tomoyuki, MD, Nishida, Kohji, MD, Tano, Yasuo, MD
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.03.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery. Setting Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan. Methods Eyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC50 , MIC90 , mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically. Results Of the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes ; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus , including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium . Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus , 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes ( P <.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains ( P >.05, McNemar test). Conclusion Because many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
AbstractList To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery. Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan. Eyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC 50, MIC 90, mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically. Of the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus, including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium. Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus, 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes ( P<.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains ( P>.05, McNemar test). Because many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
PURPOSETo compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery.SETTINGOsaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan.METHODSEyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC(50), MIC(90), mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically.RESULTSOf the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus, including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium. Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus, 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes (P<.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains (P>.05, McNemar test).CONCLUSIONBecause many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery. Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan. Eyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC(50), MIC(90), mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically. Of the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus, including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium. Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus, 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes (P<.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains (P>.05, McNemar test). Because many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
Purpose To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients having ocular surgery. Setting Osaka University Hospital, Osaka, and Tohoku University Hospital, Miyagi, Japan. Methods Eyes of patients were examined preoperatively. Aerobic and anaerobic cultures were obtained from conjunctival swabs. The minimum inhibitory concentrations (MICs) of levofloxacin, gatifloxacin, and moxifloxacin for isolated strains were determined. Using the MIC values, descriptive statistics (median, MIC50 , MIC90 , mode, and range), susceptibility, and efficacy of each fluoroquinolone were calculated for the bacteria isolated, and the data were analyzed statistically. Results Of the 200 eyes sampled, 163 (81.5%) had positive bacterial growth. From the 163 eyes, 235 bacterial strains were isolated: 116 (49.4%) Propionibacterium acnes ; 58 (24.7%) coagulase-negative Staphylococcus (CNS), including 36 methicillin-sensitive CNS (MS-CNS) and 22 methicillin-resistant CNS (MR-CNS); 10 (4.3%) Staphylococcus aureus , including 6 methicillin-sensitive S aureus and 4 methicillin-resistant S aureus (MRSA); and 29 (12.3%) Corynebacterium . Approximately 40% of Staphylococci (22/58 CNS, 37.9%; 4/10 S aureus , 40.0%) were methicillin-resistant. Furthermore, 18 (81.8%) of MR-CNS and all 4 MRSA were fluoroquinolone resistant. The MICs of moxifloxacin and gatifloxacin were statistically significantly lower than those of levofloxacin for CNS and P acnes ( P <.05, Kruskal-Wallis test). However, there was no statistically significant difference in the susceptibility patterns of the fluoroquinolones for these strains ( P >.05, McNemar test). Conclusion Because many methicillin-resistant and fluoroquinolone-resistant strains were isolated from the conjunctiva preoperatively, clinicians should be mindful of endophthalmitis or ocular infections associated with these strains.
Author Kubota, Akira, MD
Maeda, Naoyuki, MD
Nishida, Kohji, MD
Hori, Yuichi, MD
Inoue, Tomoyuki, MD
Tano, Yasuo, MD
Nakazawa, Toru, MD
Yokokura, Syunji, MD
Sakamoto, Masako, MS
Author_xml – sequence: 1
  fullname: Hori, Yuichi, MD
– sequence: 2
  fullname: Nakazawa, Toru, MD
– sequence: 3
  fullname: Maeda, Naoyuki, MD
– sequence: 4
  fullname: Sakamoto, Masako, MS
– sequence: 5
  fullname: Yokokura, Syunji, MD
– sequence: 6
  fullname: Kubota, Akira, MD
– sequence: 7
  fullname: Inoue, Tomoyuki, MD
– sequence: 8
  fullname: Nishida, Kohji, MD
– sequence: 9
  fullname: Tano, Yasuo, MD
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21200688$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19251140$$D View this record in MEDLINE/PubMed
BookMark eNp9kUuL1TAUgIOMOHdG_4AL6UZ3reckfaQgwjDoKAy4GF25CGl6CqltUpN24P57U-5FwcWQQELynUe-XLEL5x0x9hqhQMD6_ViMJsSCA8gCsYCyfcYOKBuRlxXwC3YAKetciAou2VWMIwCUXFQv2CW2vEIs4cB-PmzR0LLazk52PWbGz4sONnoXMz9kzodZT9kSyC8U9GofKSFu3JxJ-3TTabNSsDpbfTZMmw_-92adn1Kn8SV7Pugp0qvzes1-fP70_fZLfv_t7uvtzX1uKqjWvNNadsb0rRjSENBL2QsQQ9NqwEogpGPsSJdlB71uSl7W9aCrpmxxQEmduGbvTnmXvTrFVc02PWqatCO_RVXXbZrQJJCfQBN8jIEGtQQ763BUCGpXqka1K1W7UoWoktIU9Oacfetm6v-FnB0m4O0Z0NHoaQjaGRv_chxTtlrKxH04cZRcPFoKKhpLzlBvA5lV9d4-3cfH_8LNZJ1NFX_RkeLot-CSZYUqcgXqYf_8_e9BAnIuavEHO9Kt6A
CODEN JCSUEV
CitedBy_id crossref_primary_10_1097_ICO_0b013e3182a4810f
crossref_primary_10_1097_ICU_0b013e3283350158
crossref_primary_10_1136_bmjopen_2012_001206
crossref_primary_10_3341_jkos_2011_52_12_1440
crossref_primary_10_3341_jkos_2015_56_2_199
crossref_primary_10_1038_eye_2010_236
crossref_primary_10_3341_kjo_2015_29_1_7
crossref_primary_10_4103_abr_abr_155_19
crossref_primary_10_1097_ICU_0000000000000216
crossref_primary_10_1016_j_ajo_2012_06_024
crossref_primary_10_1016_j_cmi_2015_01_028
crossref_primary_10_1016_j_exer_2013_06_003
crossref_primary_10_1016_j_ophtha_2010_03_034
crossref_primary_10_1586_eop_09_70
crossref_primary_10_1016_j_oftale_2014_01_007
crossref_primary_10_1016_j_oftal_2013_06_007
crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023044057
crossref_primary_10_1016_j_jcrs_2014_05_050
crossref_primary_10_1016_j_ymed_2011_08_009
crossref_primary_10_18008_1816_5095_2020_1_111_116
crossref_primary_10_1007_s10384_012_0201_0
crossref_primary_10_1089_jop_2018_0088
crossref_primary_10_1167_iovs_19_27719
crossref_primary_10_1128_JCM_00846_13
crossref_primary_10_1016_j_ajo_2009_08_023
crossref_primary_10_1016_j_jcrs_2011_06_018
crossref_primary_10_1097_IJG_0000000000000347
crossref_primary_10_1038_eye_2016_143
crossref_primary_10_1136_bmjopen_2017_017352
crossref_primary_10_1016_j_jcrs_2014_09_023
Cites_doi 10.1016/S0161-6420(01)00899-5
10.1016/j.jcrs.2007.08.035
10.1016/j.ajo.2007.08.031
10.1016/j.jcrs.2007.04.015
10.1016/j.jcrs.2004.04.056
10.1016/S0021-5155(98)00047-1
10.1016/S0002-9394(03)00294-0
10.1007/s00417-003-0742-5
10.1016/j.diagmicrobio.2006.04.017
10.1016/S0161-6420(00)00179-2
10.1016/j.ophtha.2003.10.032
10.1016/j.jcrs.2007.06.026
10.1016/j.ajo.2003.10.026
10.3928/1542-8877-20040301-14
10.1016/j.ajo.2008.06.003
10.1016/j.jcrs.2005.12.108
10.1097/00055735-200102000-00012
10.1159/000055659
10.1001/archopht.124.4.479
10.1097/01.ico.0000263125.99262.42
10.1016/j.ajo.2005.11.055
10.1016/j.jcrs.2006.02.021
10.1076/ceyr.28.5.337.28676
10.1016/j.survophthal.2005.06.002
10.1016/j.ajo.2004.10.007
10.1016/j.ophtha.2005.06.025
ContentType Journal Article
Copyright ASCRS and ESCRS
2009 ASCRS and ESCRS
2009 INIST-CNRS
Copyright_xml – notice: ASCRS and ESCRS
– notice: 2009 ASCRS and ESCRS
– notice: 2009 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jcrs.2008.11.049
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-4502
EndPage 479
ExternalDocumentID 10_1016_j_jcrs_2008_11_049
19251140
21200688
S0886335008012236
1_s2_0_S0886335008012236
Genre Journal Article
Comparative Study
GroupedDBID -
08R
0R
1-
1B1
1P
1~5
29K
4.4
457
4G.
53G
5GY
5VS
7-5
AAEDT
AAGIX
AAHPQ
AALRI
AAQFI
AAQKA
AAQQT
AAQXK
AAXUO
ABASU
ABDIG
ABFLS
ABIID
ABLJU
ABMAC
ABPTK
ACGFO
ACGFS
ACIUM
ADBBV
ADPAM
AENEX
AEVXI
AFCTW
AFDTB
AFRHN
AFTJW
AGZHU
AITUG
AJIOK
AJUYK
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
ALXNB
AMJPA
AMKUR
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
C5W
CS3
D-I
DIWNM
DU5
EBS
EJD
F5P
FDB
FEDTE
FGOYB
FO
GBLVA
GJ
GQDEL
HVGLF
HZ
IHE
IKREB
IKYAY
IPNFZ
J1W
K
K-O
KOM
L7B
M41
MO0
NQ-
O9-
OF-
OPF
OQ
OVD
P2P
R2-
RIG
ROL
RPZ
SEL
SES
SJN
SSZ
TEORI
TSPGW
UHS
UV1
XH2
XPP
Z5R
ZA5
ZGI
ZXP
ZZMQN
---
--K
.1-
.FO
.GJ
0R~
1P~
AAEDW
AASCR
ABJNI
ABVCZ
ACILI
ADGGA
ADHPY
ADMUD
AEETU
AHOMT
AINUH
AJNWD
AMNEI
C45
EEVPB
ERAAH
FCALG
GNXGY
HLJTE
HZ~
OQ~
RLZ
IQODW
AAAAV
AAIQE
ACXJB
AHQNM
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AJZMW
CITATION
7X8
ID FETCH-LOGICAL-c505t-baa8bccd93f3f330d88d303f79a015310f3f1bea44b0da742466fa57491f18eb3
ISSN 0886-3350
IngestDate Fri Aug 16 01:30:54 EDT 2024
Fri Aug 23 01:00:22 EDT 2024
Thu May 23 23:13:31 EDT 2024
Sun Oct 22 16:07:08 EDT 2023
Fri Feb 23 02:23:08 EST 2024
Thu Aug 18 18:34:55 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Fluoroquinolone derivatives
Sensitivity
Treatment
Surgery
Bacteria
Ophthalmology
Preoperative
Antibacterial agent
Conjunctiva
Normal
Comparative study
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c505t-baa8bccd93f3f330d88d303f79a015310f3f1bea44b0da742466fa57491f18eb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19251140
PQID 66966907
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_66966907
crossref_primary_10_1016_j_jcrs_2008_11_049
pubmed_primary_19251140
pascalfrancis_primary_21200688
elsevier_sciencedirect_doi_10_1016_j_jcrs_2008_11_049
elsevier_clinicalkeyesjournals_1_s2_0_S0886335008012236
PublicationCentury 2000
PublicationDate 2009-03-01
PublicationDateYYYYMMDD 2009-03-01
PublicationDate_xml – month: 03
  year: 2009
  text: 2009-03-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Journal of cataract and refractive surgery
PublicationTitleAlternate J Cataract Refract Surg
PublicationYear 2009
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Moshirfar, Mirzaian, Feiz, Kang (bib15) 2006; 32
O'Brien, Arshinoff, Mah (bib3) 2007; 33
Thibodeaux, Dajcs, Caballero, Marquart, Girgis, O'Callaghan (bib21) 2004; 28
Hori, Maeda, Sakamoto, Koh, Inoue, Tano (bib9) 2008; 146
Jhanji, Sharma, Satpathy, Titiyal (bib16) 2007; 33
Miño de Kaspar, Koss, He, Blumenkranz, Ta (bib23) 2005; 139
Fukuda, Ohashi, Matsumoto, Mishima, Shimomura (bib13) 2002; 21
Marangon, Miller, Muallem, Romano, Alfonson (bib8) 2004; 137
Hollander, Vagefi, Seiff, Poothullil, Jeng (bib18) 2006; 141
Barry, Seal, Gettinby, Peterson, Revie (bib26) 2006; 32
Iihara, Suzuki, Kawamura, Ohkusu, Inoue, Zhang, Shah, Katagiri, Ohashi, Ezaki (bib14) 2006; 56
Kowalski, Dhaliwal, Karenchak, Romanowski, Mah, Ritterband, Gordon (bib20) 2003; 136
Ta, Singh, Egbert, Mino de Kaspar (bib24) 2008; 34
Ferrer, Ruiz-Moreno, Rodríguez, Montero, Alió (bib19) 2004; 30
Miller, Flynn, Scott, Alfonso, Flynn (bib6) 2006; 124
Ciulla, Starr, Masket (bib25) 2002; 109
Miño de Kaspar, Chang, Shriver, Singh, Egbert, Blumenkranz, Ta (bib2) 2004; 111
Kato, Hayasaka (bib11) 1998; 42
Stroman, Dajcs, Cupp, Schlech (bib22) 2005; 50
Kowalski, Yates, Romanowski, Karenchak, Mah, Gordon (bib10) 2005; 112
Alexandrakis, Alfonso, Miller (bib5) 2000; 107
Liesegang (bib1) 2001; 12
Hollander, Stewart, Seiff, Stewart (bib17) 2004; 35
Miño de Kaspar, Shriver, Nguyen, Egbert, Singh, Blumenkranz, Ta (bib7) 2003; 241
Miño de Kaspar, Kreutzer, Aguirre-Romo, Ta, Dudichum, Bayrhof, Klauss, Kampik (bib4) 2008; 145
Watanabe, Numata-Watanabe, Hayasaka (bib12) 2001; 33
Thibodeaux (R21-23-20210210) 2004; 28
Liesegang (R1-23-20210210) 2001; 12
Iihara (R14-23-20210210) 2006; 56
OBrien (R3-23-20210210) 2007; 33
Fukuda (R13-23-20210210) 2002; 21
Barry (R26-23-20210210) 2006; 32
Hollander (R18-23-20210210) 2006; 141
Moshirfar (R15-23-20210210) 2006; 32
Ferrer (R19-23-20210210) 2004; 30
Ciulla (R25-23-20210210) 2002; 109
Ta (R24-23-20210210) 2008; 34
Mino de Kaspar (R23-23-20210210) 2005; 139
Mino de Kaspar (R7-23-20210210) 2003; 241
Alexandrakis (R5-23-20210210) 2000; 107
Hollander (R17-23-20210210) 2004; 35
Marangon (R8-23-20210210) 2004; 137
Miller (R6-23-20210210) 2006; 124
Mino de Kaspar (R2-23-20210210) 2004; 111
Jhanji (R16-23-20210210) 2007; 33
Hori (R9-23-20210210) 2008; 146
Kowalski (R10-23-20210210) 2005; 112
Mino de Kaspar (R4-23-20210210) 2008; 145
Kowalski (R20-23-20210210) 2003; 136
Stroman (R22-23-20210210) 2005; 50
Watanabe (R12-23-20210210) 2001; 33
Kato (R11-23-20210210) 1998; 42
References_xml – volume: 241
  start-page: 730
  year: 2003
  end-page: 733
  ident: bib7
  article-title: Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Ta
– volume: 32
  start-page: 515
  year: 2006
  end-page: 518
  ident: bib15
  article-title: Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Kang
– volume: 112
  start-page: 1987
  year: 2005
  end-page: 1991
  ident: bib10
  article-title: An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data
  publication-title: Ophthalmology
  contributor:
    fullname: Gordon
– volume: 34
  start-page: 171
  year: 2008
  end-page: 172
  ident: bib24
  article-title: Prospective comparative evaluation of povidone–iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Mino de Kaspar
– volume: 56
  start-page: 297
  year: 2006
  end-page: 303
  ident: bib14
  article-title: Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections
  publication-title: Diagn Microbiol Infect Dis
  contributor:
    fullname: Ezaki
– volume: 141
  start-page: 949
  year: 2006
  end-page: 951
  ident: bib18
  article-title: Bacterial endophthalmitis after resident-performed cataract surgery
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Jeng
– volume: 33
  start-page: 1488
  year: 2007
  end-page: 1489
  ident: bib16
  article-title: Fourth-generation fluoroquinolone-resistant bacterial keratitis
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Titiyal
– volume: 30
  start-page: 2441
  year: 2004
  end-page: 2444
  ident: bib19
  article-title: Postoperative corynebacterium macginleyi endophthalmitis
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Alió
– volume: 107
  start-page: 1497
  year: 2000
  end-page: 1502
  ident: bib5
  article-title: Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones
  publication-title: Ophthalmology
  contributor:
    fullname: Miller
– volume: 111
  start-page: 1352
  year: 2004
  end-page: 1355
  ident: bib2
  article-title: Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery; a prospective randomized study
  publication-title: Ophthalmology
  contributor:
    fullname: Ta
– volume: 145
  start-page: 136
  year: 2008
  end-page: 142
  ident: bib4
  article-title: A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Kampik
– volume: 12
  start-page: 68
  year: 2001
  end-page: 74
  ident: bib1
  article-title: Use of antimicrobials to prevent postoperative infection in patients with cataracts
  publication-title: Curr Opin Ophthalmol
  contributor:
    fullname: Liesegang
– volume: 35
  start-page: 159
  year: 2004
  end-page: 161
  ident: bib17
  article-title: Late-onset Corynebacterium endophthalmitis following laser posterior capsulotomy
  publication-title: Ophthalmic Surg Lasers Imaging
  contributor:
    fullname: Stewart
– volume: 146
  start-page: 729
  year: 2008
  end-page: 734
  ident: bib9
  article-title: Bacteriologic profile of the conjunctiva in the patients with dry eye
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Tano
– volume: 124
  start-page: 479
  year: 2006
  end-page: 483
  ident: bib6
  article-title: In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Flynn
– volume: 136
  start-page: 500
  year: 2003
  end-page: 505
  ident: bib20
  article-title: Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Gordon
– volume: 42
  start-page: 461
  year: 1998
  end-page: 465
  ident: bib11
  article-title: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients
  publication-title: Jpn J Ophthalmol
  contributor:
    fullname: Hayasaka
– volume: 21
  start-page: S86
  year: 2002
  end-page: S89
  ident: bib13
  article-title: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops
  publication-title: Cornea
  contributor:
    fullname: Shimomura
– volume: 28
  start-page: 337
  year: 2004
  end-page: 342
  ident: bib21
  article-title: Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis
  publication-title: Curr Eye Res
  contributor:
    fullname: O'Callaghan
– volume: 32
  start-page: 407
  year: 2006
  end-page: 410
  ident: bib26
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study
  publication-title: the ESCRS Endophthalmitis Study Group J Cataract Refract Surg
  contributor:
    fullname: Revie
– volume: 33
  start-page: 1790
  year: 2007
  end-page: 1800
  ident: bib3
  article-title: Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin
  publication-title: J Cataract Refract Surg
  contributor:
    fullname: Mah
– volume: 139
  start-page: 730
  year: 2005
  end-page: 733
  ident: bib23
  article-title: Antibiotic susceptibility of preoperative normal conjunctival bacteria
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Ta
– volume: 109
  start-page: 13
  year: 2002
  end-page: 24
  ident: bib25
  article-title: Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update
  publication-title: Ophthalmology
  contributor:
    fullname: Masket
– volume: 50
  start-page: S16
  year: 2005
  end-page: S31
  ident: bib22
  article-title: In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%; a new topical fluoroquinolone
  publication-title: Surv Ophthalmol
  contributor:
    fullname: Schlech
– volume: 33
  start-page: 136
  year: 2001
  end-page: 139
  ident: bib12
  article-title: Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas
  publication-title: Ophthalmic Res
  contributor:
    fullname: Hayasaka
– volume: 137
  start-page: 453
  year: 2004
  end-page: 458
  ident: bib8
  article-title: Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Alfonson
– volume: 109
  start-page: 13
  year: 2002
  ident: R25-23-20210210
  article-title: Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(01)00899-5
  contributor:
    fullname: Ciulla
– volume: 34
  start-page: 171
  year: 2008
  ident: R24-23-20210210
  article-title: Prospective comparative evaluation of povidone-iodine (10 for 5 minutes versus 5 for 1 minute) as prophylaxis for ophthalmic surgery.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2007.08.035
  contributor:
    fullname: Ta
– volume: 145
  start-page: 136
  year: 2008
  ident: R4-23-20210210
  article-title: A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2007.08.031
  contributor:
    fullname: Mino de Kaspar
– volume: 33
  start-page: 1488
  year: 2007
  ident: R16-23-20210210
  article-title: Fourth-generation fluoroquinolone-resistant bacterial keratitis.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2007.04.015
  contributor:
    fullname: Jhanji
– volume: 30
  start-page: 2441
  year: 2004
  ident: R19-23-20210210
  article-title: Postoperative corynebacterium macginleyi endophthalmitis.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2004.04.056
  contributor:
    fullname: Ferrer
– volume: 42
  start-page: 461
  year: 1998
  ident: R11-23-20210210
  article-title: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients.
  publication-title: Jpn J Ophthalmol
  doi: 10.1016/S0021-5155(98)00047-1
  contributor:
    fullname: Kato
– volume: 136
  start-page: 500
  year: 2003
  ident: R20-23-20210210
  article-title: Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(03)00294-0
  contributor:
    fullname: Kowalski
– volume: 241
  start-page: 730
  year: 2003
  ident: R7-23-20210210
  article-title: Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery.
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-003-0742-5
  contributor:
    fullname: Mino de Kaspar
– volume: 56
  start-page: 297
  year: 2006
  ident: R14-23-20210210
  article-title: Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections.
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2006.04.017
  contributor:
    fullname: Iihara
– volume: 107
  start-page: 1497
  year: 2000
  ident: R5-23-20210210
  article-title: Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones.
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(00)00179-2
  contributor:
    fullname: Alexandrakis
– volume: 111
  start-page: 1352
  year: 2004
  ident: R2-23-20210210
  article-title: Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery; a prospective randomized study.
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2003.10.032
  contributor:
    fullname: Mino de Kaspar
– volume: 33
  start-page: 1790
  year: 2007
  ident: R3-23-20210210
  article-title: Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2007.06.026
  contributor:
    fullname: OBrien
– volume: 137
  start-page: 453
  year: 2004
  ident: R8-23-20210210
  article-title: Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2003.10.026
  contributor:
    fullname: Marangon
– volume: 35
  start-page: 159
  year: 2004
  ident: R17-23-20210210
  article-title: Late-onset Corynebacterium endophthalmitis following laser posterior capsulotomy.
  publication-title: Ophthalmic Surg Lasers Imaging
  doi: 10.3928/1542-8877-20040301-14
  contributor:
    fullname: Hollander
– volume: 146
  start-page: 729
  year: 2008
  ident: R9-23-20210210
  article-title: Bacteriologic profile of the conjunctiva in the patients with dry eye.
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2008.06.003
  contributor:
    fullname: Hori
– volume: 32
  start-page: 515
  year: 2006
  ident: R15-23-20210210
  article-title: Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
  publication-title: J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2005.12.108
  contributor:
    fullname: Moshirfar
– volume: 12
  start-page: 68
  year: 2001
  ident: R1-23-20210210
  article-title: Use of antimicrobials to prevent postoperative infection in patients with cataracts.
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/00055735-200102000-00012
  contributor:
    fullname: Liesegang
– volume: 33
  start-page: 136
  year: 2001
  ident: R12-23-20210210
  article-title: Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas.
  publication-title: Ophthalmic Res
  doi: 10.1159/000055659
  contributor:
    fullname: Watanabe
– volume: 124
  start-page: 479
  year: 2006
  ident: R6-23-20210210
  article-title: In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates.
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.124.4.479
  contributor:
    fullname: Miller
– volume: 21
  start-page: S86
  issue: suppl 2
  year: 2002
  ident: R13-23-20210210
  article-title: Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops.
  publication-title: Cornea
  doi: 10.1097/01.ico.0000263125.99262.42
  contributor:
    fullname: Fukuda
– volume: 141
  start-page: 949
  year: 2006
  ident: R18-23-20210210
  article-title: Bacterial endophthalmitis after resident-performed cataract surgery.
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2005.11.055
  contributor:
    fullname: Hollander
– volume: 32
  start-page: 407
  year: 2006
  ident: R26-23-20210210
  article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study.
  publication-title: the ESCRS Endophthalmitis Study Group J Cataract Refract Surg
  doi: 10.1016/j.jcrs.2006.02.021
  contributor:
    fullname: Barry
– volume: 28
  start-page: 337
  year: 2004
  ident: R21-23-20210210
  article-title: Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis.
  publication-title: Curr Eye Res
  doi: 10.1076/ceyr.28.5.337.28676
  contributor:
    fullname: Thibodeaux
– volume: 50
  start-page: S16
  issue: suppl
  year: 2005
  ident: R22-23-20210210
  article-title: In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5; a new topical fluoroquinolone.
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2005.06.002
  contributor:
    fullname: Stroman
– volume: 139
  start-page: 730
  year: 2005
  ident: R23-23-20210210
  article-title: Antibiotic susceptibility of preoperative normal conjunctival bacteria.
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2004.10.007
  contributor:
    fullname: Mino de Kaspar
– volume: 112
  start-page: 1987
  year: 2005
  ident: R10-23-20210210
  article-title: An ophthalmologists guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.06.025
  contributor:
    fullname: Kowalski
SSID ssj0004235
Score 2.1183612
Snippet Purpose To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in...
To compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in patients...
PURPOSETo compare the susceptibility and efficacy of 3 fluoroquinolones, (levofloxacin, gatifloxacin, and moxifloxacin) in treating conjunctival bacteria in...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 475
SubjectTerms Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - pharmacology
Aza Compounds - pharmacology
Bacteria - drug effects
Bacteria - isolation & purification
Biological and medical sciences
Conjunctiva - microbiology
Female
Fluoroquinolones - pharmacology
Humans
Levofloxacin
Male
Medical sciences
Microbial Sensitivity Tests
Middle Aged
Ofloxacin - pharmacology
Ophthalmology
Preoperative Care
Quinolines - pharmacology
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the eye and orbit
Title Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0886335008012236
https://dx.doi.org/10.1016/j.jcrs.2008.11.049
https://www.ncbi.nlm.nih.gov/pubmed/19251140
https://search.proquest.com/docview/66966907
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhLgTLiMPvE2pkti5PU4INDGNB9qJIR4sJ7FFLzRVk4C2X89xjnNpRxGgSlGVpE6b74v9-fQ7x4S8YYkPmo3ljvJC1wFF7DqJULETSwmzg8CTflNS6PxjeHrBPlwGl6PRj4Frqa7ScXb927yS_0EV9gGuOkv2H5DtGoUd8B7whS0gDNu_wnhSl40rpTG4Xhk_ubYHoT9Dy9GlrgJQrKUp8A2z3zmMZHpNs-VxipWahdafalkXepCY6Tj7yhgLb4pWHe3ReVVoS5eqybGCdstBdnVjxsUE9i_1LPs26wLOYiGuxc9Grk6LTd1Hw2UusKsvrupFd_4EzgcmFZhTVIpFsRWjSHqT1lhivxpH1GGBu9XxYp0SQzA66EUZLqZyo3fHQMN8PM82JdpgdQFWLHk6gHv9vcEbtCuoSSwGtVNTuz10ixwCFwOYtB-enH36fNZn1Po0MClW6AbcvWRTbBYb2ado7q5FCc-ZwgVS9s9gGiUzvU_uGTTtE-TTAzKSq4fk9rkxWTwiX7dpZQ9oZRfKRlrZQ1rZQ1rZLa3sqrB3afWYXLx_N3176pg1OJwMtHHlpELEaZblCVXwom4exzmoHhUlAoQkzA1gt5dKwVjq5iJiPgtDJYKIJZ7yYpnSJ-RgBe0_I7bKWM4UjWiepSDC3URr2YRSLwt1mCK3yHF7H_kaS63w1oM45xoAXDMVZqwAgEWi9lbzNokYhj1Zmuez5B4vfe7yCYyjIaWBnht5IIZDiwTdJ43MRPnIgWd_vOLRFqLdlwT1pzOtYou8biHm0Enrf97EShZ1ycMwCXUYyiJPEfn-BxoSPd975AW50z9SL8lBtanlKxDCVXpkWPsLuN64wg
link.rule.ids 315,786,790,27957,27958
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Susceptibility+comparisons+of+normal+preoperative+conjunctival+bacteria+to+fluoroquinolones&rft.jtitle=Journal+of+cataract+and+refractive+surgery&rft.au=Hori%2C+Yuichi&rft.au=Nakazawa%2C+Toru&rft.au=Maeda%2C+Naoyuki&rft.au=Sakamoto%2C+Masako&rft.date=2009-03-01&rft.eissn=1873-4502&rft.volume=35&rft.issue=3&rft.spage=475&rft_id=info:doi/10.1016%2Fj.jcrs.2008.11.049&rft_id=info%3Apmid%2F19251140&rft.externalDocID=19251140
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08863350%2FS0886335009X00027%2Fcov150h.gif